Search Climate Insights Directory

The report details how the rapid growth of the viscose industry in China, India, and Indonesia has led to severe water and air pollution, causing health crises such as cancer and birth defects in local communities. It identifies a lack of transparency in the fashion supply chain and finds that major brands, including H&M, Zara (Inditex), and ASOS, source materials from these polluting factories. The document argues that because the industry is highly concentrated—with 70% of global viscose produced by ten factories—major brands have the leverage to force a transition toward closed-loop production systems and less toxic chemicals.

The report details how the production of viscose, often marketed as an ecological alternative to cotton or synthetics, involves highly polluting chemical processes in China, India, and Indonesia. It documents the discharge of untreated wastewater into local water sources, leading to severe health issues such as cancer and congenital deformities, and the destruction of local ecosystems and traditional livelihoods. The investigation reveals that major global fashion brands, including H&M, Inditex (Zara), and ASOS, source their viscose from these polluting factories. The document argues that because a small group of 10 companies controls approximately 70% of global viscose production, large fashion brands have the purchasing power to force a transition toward closed-loop, less toxic production systems.

The report highlights Germany's position as a leading producer of packaging waste in Europe, with 218 kg per person annually. It argues that supermarkets and drugstores hold significant power to reduce this waste by replacing resource-inefficient products—such as single-use plastic bottles and non-concentrated detergents—with sustainable alternatives. The document claims that a 20% reduction in resource consumption is currently possible through product innovation and the adoption of reusable systems. It criticizes the 2017 German Packaging Act for focusing on recycling rather than avoidance and calls for a resource tax, binding reusable quotas, and clearer consumer labeling to drive a transition toward a circular economy.

The report argues that California's carpet stewardship program, led by the industry-controlled Carpet America Recovery Effort (CARE), has failed to meet recycling goals and instead increased the incineration of carpet waste. It contends that incineration—including Waste-to-Energy (WTE), cement kilns, and Carpet as Alternative Fuel (CAAF)—is a wasteful practice that violates the California Public Resources Code's waste management hierarchy. The document highlights significant environmental and health risks, noting that burning carpets containing PVC releases dioxins and unregulated nanoparticles. Financially, it claims WTE is the most expensive energy generation method in the U.S. and can lead to municipal bankruptcy. From a climate perspective, it cites CalRecycle data showing that WTE incineration adds approximately 26,000 metric tons of CO2, whereas recycling saves about 36,000 metric tons. The authors recommend that CalRecycle reject CARE as the stewardship organization and mandate an industry-funded program with enforceable recycling targets.

The report examines the carpet sector's failure to transition from a linear to a circular economy, highlighting that most carpets in Europe are incinerated or landfilled. It specifically critiques industry leaders Desso and Interface for 'greenwashing,' noting a significant gap between their sustainability goals and actual collection rates. The document also identifies the event industry as a major source of single-use carpet waste and proposes systemic changes in eco-design, collection infrastructure, and public policy to enable genuine closed-loop recycling.

The report examines the transition of the carpet industry toward a circular economy, focusing on the French and European markets. It finds that the vast majority of carpets end up in landfills or incinerators, with actual recycling rates for industry leaders like Interface and Desso being significantly lower than their public commitments. The document specifically highlights the 'scandal' of single-use carpets in the French events sector and provides recommendations for manufacturers, policymakers, and consumers to implement closed-loop systems and eco-design.

The report finds that despite the promotion of circular economy goals, the vast majority of carpets in Germany are incinerated and 60% in Europe are landfilled. It highlights a significant discrepancy between the environmental claims of industry leaders Interface and Desso and their actual reclamation rates, which are approximately 1.5% and 3% respectively. The document argues that structural issues, including poor product design, lack of separate collection systems, and an overcapacity of waste incinerators in Germany, hinder the transition to a closed-loop system. It recommends the introduction of product stewardship (Extended Producer Responsibility), an incineration tax, and mandatory bulky waste regulations to incentivise recycling over burning.

The report argues that the European carpet industry is far from achieving a circular economy, with the vast majority of carpets in Germany being incinerated and 60% in Europe being landfilled. Despite the public sustainability branding of market leaders Desso and Interface, the study finds that these companies recover only 1.5% to 3% of the carpets they place on the market. The document identifies structural barriers, including poor eco-design, a lack of comprehensive collection systems, and an overcapacity of waste incineration plants in Germany, which creates financial incentives to burn recyclable materials. It recommends the introduction of extended producer responsibility, a waste incineration tax, and mandatory recycling quotas to shift the industry toward genuine material recovery.

The report highlights a critical lack of transparency in the antibiotic supply chain for the French market, noting that while formulation often occurs in Europe, active pharmaceutical ingredients (APIs) are primarily sourced from India and China. It documents severe environmental pollution and the proliferation of antibiotic-resistant bacteria around production sites in these countries, linking specific manufacturers like Aurobindo and Mylan to these impacts. The document argues that current French public procurement processes fail to account for these environmental risks and calls for a global audit and stricter transparency requirements to combat antimicrobial resistance.

The U.S. carpet industry is characterized by high waste, with 89% of discarded carpets ending up in landfills and 6% being incinerated. Despite the existence of the Carpet America Recovery Effort (CARE), only 1% of carpet waste is recycled back into carpet in a closed loop. The report argues that major manufacturers, particularly Shaw and Mohawk, engage in greenwashing and actively lobby against Extended Producer Responsibility (EPR) legislation to maintain a wasteful linear model. In California, the AB 2398 law has failed to achieve meaningful recycling increases because it relies on consumer fees rather than producer funding, and is administered by CARE, which the report claims is under the influence of the industry's largest players.

The report identifies pharmaceutical manufacturing as a critical third driver of antimicrobial resistance (AMR), alongside human and animal misuse. Field research in India revealed high levels of drug-resistant E. coli near factories in Hyderabad, Chennai, and Delhi, specifically linking Aurobindo Pharma, Orchid Chemicals, and Asiatic Drugs & Pharmaceuticals to these hotspots. The document details a complex global supply chain where Chinese firms produce active pharmaceutical ingredients (APIs) under poor environmental conditions, which are then processed in India and exported to Western healthcare systems, including the UK's NHS and US distributors like McKesson. It concludes that current regulatory inspections focus on product safety rather than environmental impact, allowing pollution to accelerate a global health crisis.

The report details the presence of antibiotic-resistant bacteria near pharmaceutical production sites in India and China, arguing that poor waste management in these hubs fuels the global spread of 'superbugs'. Through water sampling and supply chain analysis, it identifies specific companies—such as Aurobindo Pharma, Orchid Chemicals, and Asiatic Drugs and Pharmaceuticals—as 'AMR hotspots' and traces their products to major healthcare providers and pharmaceutical giants in the West.

The report identifies a critical link between irresponsible pharmaceutical manufacturing practices in China and India and the proliferation of 'superbugs'. Field sampling in India revealed high levels of antibiotic resistance in water sources near factories owned by Aurobindo Pharma, Orchid Chemicals, and Asiatic Drugs and Pharmaceuticals. The analysis shows that these polluting sites are integrated into global supply chains, providing active pharmaceutical ingredients (APIs) and finished drugs to major distributors and healthcare providers in the West, including McKesson in the US and various public hospitals in France. The document argues that antimicrobial resistance is driven by three factors—medical, agricultural, and industrial—and calls for the integration of environmental criteria into Good Manufacturing Practices (GMP) and greater supply chain transparency.

The report identifies pharmaceutical manufacturing waste in India and China as a significant driver of antimicrobial resistance (AMR). Through water sampling in India and supply chain analysis, it links specific polluting factories to major global distributors and public health systems, including the UK's NHS. It argues that current Good Manufacturing Practice (GMP) frameworks are insufficient because they lack environmental criteria, allowing 'superbugs' to proliferate and spread globally via trade and travel.

The document identifies environmental pollution from antibiotic manufacturing in China and India as a key cause of antimicrobial resistance (AMR), contributing to a global health crisis where common medical procedures could become high-risk. It highlights a lack of transparency in the pharmaceutical supply chain and urges the NHS and other large buyers to blacklist companies that dump inadequately treated antibiotic waste.

The document examines how the pharmaceutical industry contributes to the global rise of 'superbugs' through the discharge of antibiotic-laden waste into the environment, particularly in China and India. It highlights a critical lack of transparency in the supply chain and argues that current Good Manufacturing Practices (GMP) fail to include environmental criteria. The report provides case studies of specific companies—such as NCPC, CSPC, and Aurobindo—linked to environmental violations and calls on German health authorities (BfArM) and procurement bodies (BVBG) to integrate environmental and AMR criteria into their licensing and purchasing processes to prevent the further spread of drug-resistant bacteria.

The report finds that ten major European personal care retailers are failing to take responsibility for resource efficiency, with none reporting targets or measurements for the overall resource impact of their product assortments. While a Wuppertal Institute study suggests a 20 per cent reduction in resource use is possible through existing alternatives like concentrated detergents and compressed deodorants, retailers generally lack time-bound objectives for recycled packaging or waste reduction. The report ranks Kruidvat as the best performer among the studied group, while Douglas scored zero on resource efficiency questions. It recommends that retailers stop selling resource-inefficient products, set binding reduction targets, and demand transparency from suppliers to inform consumers at the point of sale.

The report finds that European drugstore retailers generally fail to implement strategic planning for resource efficiency, with most lacking overarching goals to reduce the resource footprint of their product ranges. While some companies implement isolated measures, such as using recycled paper or reducing plastic bags, there is a systemic lack of transparent, annual reporting on results. The document highlights that a 20% reduction in resource consumption for daily goods is already possible through the adoption of existing alternatives like concentrated detergents and compressed deodorants.

South Africa faces a severe water crisis driven by climate change, population growth, and crumbling infrastructure. The report argues that the country must shift its focus from building new infrastructure to managing demand through water efficiency. Key opportunities for savings include improving agricultural irrigation (30-40%), reducing municipal leaks and household waste (12-30%), and increasing industrial efficiency. The document emphasizes the role of the business community in disclosing water use and investing in water-saving technologies to avoid economic instability and social unrest.

The report documents severe water and soil contamination caused by the bulk drug industry in India, particularly in Telangana and Andhra Pradesh. It highlights a systemic failure of waste treatment infrastructure and regulatory oversight, linking local pollution to the global spread of antimicrobial resistance (AMR). The investigation identifies major pharmaceutical companies, including Aurobindo, Dr Reddy's, Hetero, and Mylan, as significant polluters whose products enter global markets, while local communities suffer from chronic health issues and destroyed livelihoods.